Cargando…

Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma

SIMPLE SUMMARY: The introduction of immune checkpoint inhibitors and targeted therapy for the treatment of unresectable advanced or metastatic melanoma has changed the prognosis of melanoma patients. Five-year overall survival rates for metastatic melanoma have increased from less than 10% up to 40–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comito, Francesca, Pagani, Rachele, Grilli, Giada, Sperandi, Francesca, Ardizzoni, Andrea, Melotti, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773625/ https://www.ncbi.nlm.nih.gov/pubmed/35053435 http://dx.doi.org/10.3390/cancers14020271

Ejemplares similares

Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: De Giglio, Andrea, et al.
Publicado: (2022)

BRAF‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis
por: Abbati, Francesca, et al.
Publicado: (2021)

Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
por: Dika, Emi, et al.
Publicado: (2021)

The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy
por: De Giglio, Andrea, et al.
Publicado: (2022)

Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
por: Di Federico, Alessandro, et al.
Publicado: (2022)

New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event
por: Lamberti, Giuseppe, et al.
Publicado: (2020)

Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
por: Parisi, Claudia, et al.
Publicado: (2020)

Cutaneous sarcoid‐like reaction in a patient treated with target therapy for metastatic melanoma: the hue is the clue
por: Baracca, Maria Francesca, et al.
Publicado: (2022)

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors
por: Dall’Olio, Filippo G., et al.
Publicado: (2020)

The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma
por: John, Lijo, et al.
Publicado: (2015)

Cemiplimab-Induced Alopecia Areata
por: Piraccini, Bianca Maria, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
por: Fania, Luca, et al.
Publicado: (2021)

Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
por: Tosi, Anna, et al.
Publicado: (2021)

Advances in Targeting Cutaneous Melanoma
por: Kasakovski, Dimitri, et al.
Publicado: (2021)

Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities
por: Lemech, Charlotte, et al.
Publicado: (2012)

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
por: Sigalotti, Luca, et al.
Publicado: (2010)

Recent advances in diagnosing cutaneous melanomas
por: Wurm, Elisabeth MT, et al.
Publicado: (2010)

Cutaneous melanoma: new advances in treatment()
por: Foletto, Michele Ceolin, et al.
Publicado: (2014)

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
por: Gelfo, Valerio, et al.
Publicado: (2018)

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC
por: Dall’Olio, Filippo G., et al.
Publicado: (2022)

Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014)

Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
por: Monti, Matilde, et al.
Publicado: (2020)

Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
por: Maresca, Luisa, et al.
Publicado: (2022)

Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
por: Neuendorf, Hannah M., et al.
Publicado: (2023)

SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
por: Pópulo, Helena, et al.
Publicado: (2017)

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
por: Gelsomino, Francesco, et al.
Publicado: (2021)

Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis
por: Ricci, Costantino, et al.
Publicado: (2022)

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances
por: Strashilov, Strahil, et al.
Publicado: (2021)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma
por: Montico, Barbara, et al.
Publicado: (2021)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities
por: Lai, Michele, et al.
Publicado: (2019)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Treatment of cutaneous melanoma: current approaches and future prospects
por: Algazi, Alain P, et al.
Publicado: (2010)

Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
por: Dobre, Elena-Georgiana, et al.
Publicado: (2021)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Pigmentary retinopathy associated with immune therapy for advanced cutaneous melanoma
por: Lin, Andrew C., et al.
Publicado: (2023)

Extracellular Vesicles: Emerging Therapeutics in Cutaneous Lesions
por: Li, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6obiddupnv709d2fsj67j51h6